Indonesia says CoronaVac is 65.3% effective as Chinese-made Covid-19 vaccine makes inroads in Asia | South China Morning Post

Indonesia is the first country other than China to give a regulatory green light to the CoronaVac vaccine produced by Chinese drug maker Sinovac Biotech. Indonesia’s food and drugs regulator announced its decision to authorise the vaccine on January 11, 2021, saying that drug trials found the shots to be 65.3 per ce…

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.